Medix Biochemica

community rating (0 votes):

Description

Medix Biochemica is an independent Finnish-based global leader in supplying high-quality raw materials for in vitro diagnostics. With over 5000 products available, they can supply over 95% of the most common reagents for assay development, manufacturing, and validation. Their broad portfolio and expertise support diagnostic test manufacturing worldwide. They offer a comprehensive range of antibodies, antigens, biospecimens, bulk biologicals, enzymes, immunoassay kits, lipoproteins, molecular reagents, processed plasma, proteins, and small molecules. Medix Biochemica is committed to empowering global health through rapid diagnostics and providing cutting-edge diagnostic solutions. Stay updated with their latest news and breakthroughs in the IVD world.

website

Reviews

No Reviews Yet

Be the first to review one of our webinars!

Upcoming Webinars

There are no upcoming webinars on this topic or publisher.

Previous Webinars

Healthcare > Pharmaceutical

Empowering Global Health: Rapid Diagnostics in Infectious Disease Detection from Development to Implementation

Explore the full journey of developing infectious disease lateral flow tests with experts from Lateral Dx and Medix Biochemica.Learn about critical stages in IVD development, strategies for optimizing antibody selection, and common pitfalls to avoid.Discover the real-world impact of infectious disease diagnostics on global health and see performance data from Medix Biochemica antibodies in action.After presentations, there's a Q & A session. Webinar is hosted by Anthony Austin.Date: Tuesday, May 13, 2025 Time and zone: 15:00 BST / 16:00 CEST / 10:00 EDT / 7:00 PDTDiscussion points:• Key stages of IVD test development: concept to validation• Challenges & pitfalls commonly experienced in assay development• Considerations in antibody selection and workflow efficiencies• Role of diagnostics in outbreak response• Real-world importance of accessible testing• Real and comparative data with Medix Biochemica antibodiesKey takeaways:• IVD test development requires careful planning at every stage• Antibody selection drives assay success• Common issues can be avoided early• Rapid diagnostics play a vital role in global health• Real-world data helps guide better antibody choices• Expert partnerships streamline developmentSpeakers and Host: Richard Campbell, Founder and Managing Director, Lateral DX; Amy Moore, Global Product Manager, Medix Biochemica; Anthony Austin, Global Marketing Manager, Medix Biochemica.